CA
NZ
UK
AU
IND
US
Oil markets are recalibrating expectations as the initial optimism surrounding the U.S.-Iran ceasefire gives way to operational realities. While the agreement temporarily reduced geopolitical tensions, it has not translated into a meaningful restoration of energy flows.
Even as diplomatic efforts between the United States and Iran attempt to stabilize the Middle East, developments on the ground suggest a fundamentally different trajectory. Israel’s evolving military strategy indicates preparation for a prolonged and structurally embedded conflict rather than a near-term resolution.
The fragile ceasefire in the Middle East is already showing signs of strain as Israel expands military operations into Lebanon, raising questions about the scope and durability of the agreement.
North American pension funds are reaffirming their commitment to private credit even as the asset class faces mounting scrutiny. Recent redemption pressures and liquidity concerns have raised questions about the sustainability of the sector’s rapid growth.
Chevron’s first-quarter outlook reflects the powerful impact of rising energy prices on upstream profitability. The surge in oil and gas prices, driven by geopolitical tensions in the Middle East, has significantly strengthened earnings expectations for exploration and production activities.
US equities lost momentum on Thursday, with major indices drifting near the flatline as investors confronted renewed signs of instability in the US-Iran ceasefire, undermining the brief optimism that had sent stocks surging in the previous session.
Constellation Brands (NASDAQ: STZ), the beer and wine group behind Corona and Modelo Especial in the United States, tempered investor enthusiasm on Wednesday with a full-year profit forecast that missed Wall Street expectations by a considerable margin, sending shares down 1.2 per cent in …
Byrna Technologies, the Andover, Massachusetts-based maker of non-lethal personal defence devices, delivered a bruising set of first quarter results on Thursday, missing analyst expectations on both the top and bottom lines and sending shares down nearly 5% in pre-market trading — a stark reminder …
Galmed Pharmaceuticals (NASDAQ: GLMD), a Tel Aviv-based clinical-stage biopharmaceutical company best known for its work in metabolic liver disease, has announced what it describes as a breakthrough formulation of its lead compound Aramchol — one engineered to traverse the blood-brain barrier using lipid nanoparticle …
Market Movers:On Wednesday, the top gainers were U Power Limited. (+331.63%) and Beasley Broadcast Group, Inc. (80.57%). On the contrary, Ridgetech, Inc. (-26.17%) and Jet.AI Inc. (-25.84%) declined the most the same day.
Please wait processing your request...